Introduction {#S0001}
============

The genus of *Staphylococcus* is a major Gram-positive coccus responsible for severe infections including dermatological ones. The major nosocomial pathogen is methicillin-resistant *Staphylococcus aureus* (MRSA) \[[@CIT0001], [@CIT0002]\], however coagulase-negative species (CoNS), including *S. epidermidis* and *S. xylosus*, are responsible for difficult to treat infectious diseases. The spread of multidrug resistant bacterial strains in patients, medical staff and hospital environment is largely caused by widespread use of antibiotic therapy \[[@CIT0003], [@CIT0004]\]. Many classes of antibiotics used before have become therapeutically useless. The risk of local and systemic infections development is high in hospital wards, especially in the elderly, immunosuppressed patients and those debilitated by chronic diseases \[[@CIT0005]--[@CIT0007]\].

Literature data report that essential oils are used to treat the respiratory tract, digestive system, skin infections and also may be applied in anticancer therapy and cardiovascular and nervous system disorders to reduce the level of cholesterol, as well as to decrease and regulate the glucose level. Various essential oils are components of the cosmetic cleaning products and food preservatives \[[@CIT0008]--[@CIT0011]\].

One of the most important essential oils which has been successfully used in medicine and cosmetology is tea tree oil \[[@CIT0012]\]. The study by Hammer *et al*. \[[@CIT0013]\] showed the susceptibility of transient and commensal skin flora to the essential oil of *Melaleuca alternifolia*. Their results suggest that tea tree oil may be useful in removing transient skin flora but maintains resident flora. Due to strong antifungal properties of essential oils they can be used in mixed skin infections. According to Adam *et al*. \[[@CIT0014]\], the essential oils of *Origanum vulgare* subsp. *hirtum, Mentha spicata, Lavandula angustifolia*, and *Salvia fruticosa* exhibited antifungal properties against the human pathogens of *Malassezia furfur, Trichophyton rubrum*, and *Trichosporon beigelii*. The analyzed essential oils were tested with the Ames test and did not exhibit any mutagenic activity. The genus of *Salvia* is represented by over 900 species. One of the most important medicinal plants is *Salvia officinalis*. It has been used in treatment of tuberculosis, dysentery, coughing, indigestion, ulcer, psoriasis, as well as in skin and hair care \[[@CIT0015]\]. The antimicrobial activity of plant extracts and essential oils from some species of *Salvia* is well documented in the research \[[@CIT0016], [@CIT0017]\]. Clary sage extracts and essential oil possess antioxidant and antimicrobial properties \[[@CIT0018], [@CIT0019]\]. Dźamić *et al*. \[[@CIT0020]\] showed fungicidal activity of the sage oil against *Aspergillus*, *Penicillium*, *Fusarium*, *Trichoderma*, *Mucor*, *Candida* and also its fungistatic and fungicidal activity against *Cladosporium*, *Trichophyton*, *Alternaria* and *Phoma* in very low levels. Hristova *et al*. \[[@CIT0021]\] presented interesting results connected with high activity of the clary sage oil against many clinical strains of *Candida* species.

Aim {#S0002}
===

The present study on *Staphylococcus* isolates obtained from difficult-to-heal wound infections provided the information regarding strain sensitivity to the clary sage oil.

Material and methods {#S0003}
====================

Origin and identification of bacterial strains {#S20004}
----------------------------------------------

The tested *Staphylococcus* clinical strains were isolated from the swabs of patients with recurrent, difficult-to-treat wound infections treated at the Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, Poland, in 2012. The study included 61 patients; 41 males and 20 females (mean age of 56--63 years) with non-healing wounds arising in the course of diabetes, cardiovascular disorders, burns and surgery. Before admission, these patients were subjected unsuccessfully several times to outpatient treatment. The clinical material was collected before the antibiotic therapy. Staphylococci isolated from wounds were identified according to standard methods of culturing on Columbia Agar (bioMerieux), on Mannitol Salt Agar (bioMerieux), and determining the ability of bacteria to produce catalase and coagulase (bioMerieux). Microorganism species were identified by using API Staph tests (bioMerieux). The bacteria were incubated in 37°C for 24 h. *Staphylococcus aureus* ATCC 29213 strain was used as a control.

Preparation and GC-FID-MS analysis of clary sage oil {#S20005}
----------------------------------------------------

*Salvia sclarea* L. (*Lamiaceae*) oil was obtained from POLLENA-AROMA Poland. It was analyzed by GC-FID-MS in the Institute of General Food Chemistry, Lodz University of Technology, using a Trace GC Ultra apparatus (Thermo Electron Corporation) with FID and MS DSQ II detectors and FID-MS splitter (SGE). Operating conditions: apolar capillary column Rtx-1ms (Restek), 60 m × 0.25 mm i.d., film thickness 0.25 µm; temperature program, 50--300°C at 4°C/min; SSL injector temperature 280°C; FID temperature 300°C; split ratio 1: 20; carrier gas helium at a regular pressure 200 kPa; FID temperature 260°C; carrier gas, helium; 0.5 ml/min; split ratio 1: 20. Mass spectra were acquired over the mass range 30--400 Da, ionization voltage 70 eV; ion source temperature 200°C.

Identification of components was based on the comparison of their MS spectra with those in a laboratory-made MS library, commercial libraries (NIST 98.1, Wiley Registry of Mass Spectral Data, 8th Ed. and MassFinder 4) and with literature data \[[@CIT0022], [@CIT0023]\] along with the retention indices on an apolar column (Rtx-1, MassFinder 4) associated with a series of alkanes with linear interpolation (C~8~--C~26~).

*Staphylococcus* susceptibility to antibiotic testing {#S20006}
-----------------------------------------------------

*Staphylococcus* strains were cultivated on Columbia Agar medium and incubated at 37°C for 24 h. Bacterial suspensions with an optical density of 0.5MF scale were prepared with the bioMerieux densitometer. Susceptibility testing was carried out with the use of disk-diffusion method on Mueller-Hinton II Agar and incubated at 37°C for 18 h. The following antibiotics (Becton Dickinson) were used: *Staphylococcus aureus*, *S. epidermidis* and *S. xylosus*: FOX -- cefoxitin (30 µg), P -- penicillin (10 IU), E -- erythromycin (15 µg), DA -- clindamycin (2 µg), TE -- tetracycline (30 µg), TGC -- tigecycline (15 µg), C -- chloramphenicol (30 µg), CIP -- ciprofloxacin (5 µg), RA -- rifampin (5 µg), GM -- gentamicin (10 µg), SXT -- trimethoprim-sulfamethoxazole (1.25 µg /23.75 µg), LZD -- linezolid (30 µg), FD -- fusidic acid (10 µg), QDA -- quinupristin-dalfopristin (15 µg), VA -- vancomycin (30 µg), and DPC -- daptomycin (15 µg).

The results were found according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines \[[@CIT0024]\].

*Staphylococcus* susceptibility to clary sage testing {#S20007}
-----------------------------------------------------

The clary sage antistaphylococcal activity was tested by the micro-dilution broth method. The essential oil was diluted in ethanol used as a stock solution. This stock solution was mixed with a 100 µl of Mueller-Hinton broth to obtain concentrations from 3.5 µl/ml to 7.25 µl/ml. An inoculum containing 1--2 × 10^8^ cells/ml (10 µl) per well was added to broth with various oil concentrations, as well as to broth with no oil added (strain growth control) and were transferred to 96-well microtiter plates. The minimal inhibitory concentration (MIC) was determined after 24 h of incubation at 37°C under aerobic conditions \[[@CIT0025]\]. Control media containing only alcohol (at concentrations used in the dilutions of clary sage) did not inhibit the growth of tested bacteria.

Results {#S0008}
=======

Constituents of *Salvia sclarea* oil {#S20009}
------------------------------------

Detailed analysis of the clary sage oil showed 56 constituents, out of which linalyl acetate (57.9%) and linalool (12.4%) were determined as the main ones. Moreover, α-pinene (4.5%), α-terpineol (3.5%), sabinene (3.3%), β-pinene (3.0%), geranyl acetate (1.6%), myrcene (1.5%) and neryl acetate (1.0%) were identified in large quantities ([Table 1](#T0001){ref-type="table"}).

###### 

Constituents of *Salvia sclarea* L. (clary sage) essential oil

  Number   Compound                     \%     RI
  -------- ---------------------------- ------ ------
  1        α-Thujene/Tricyclene         0.3    923
  2        α-Pinene                     4.5    931
  3        Camphene                     tr     941
  4        Sabinene                     3.3    966
  5        β-Pinene                     3.0    970
  6        Myrcene                      1.5    983
  7        α-Phellandrene               0.1    996
  8        Car-3-ene                    0.2    1004
  9        α-Terpinene                  0.4    1009
  10       p-Cymene                     0.5    1012
  11       1,8-Cineole                  0.8    1020
  12       Limonene                     0.9    1021
  13       (Z)-β-Ocimene                0.1    1028
  14       (E)-β-Ocimene                0.2    1038
  15       γ-Terpinene                  0.5    1049
  16       *trans*-Sabinene hydrate     0.1    1054
  17       *trans*-Linalool oxide (f)   tr     1059
  18       *cis*-Linalool oxide (f)     tr     1073
  19       Terpinolene                  0.3    1079
  20       Linalool                     12.4   1090
  21       *cis*-Sabinene hydrate       tr     1099
  22       *cis*-p-Menth-2-en-1-ol      tr     1108
  23       Borneol                      tr     1150
  24       Terpinen-4-ol                0.9    1163
  25       α-Terpineol                  3.5    1175
  26       γ-Terpineol                  0.2    1181
  27       Linalyl acetate              0.1    1200
  28       Nerol                        0.6    1216
  29       Ascaridole                   0.1    1221
  30       Linalyl acetate              57.9   1249
  31       Safrole                      0.2    1268
  32       α-Terpinyl acetate           0.1    1334
  33       Neryl acetate                1.0    1344
  34       α-Cubebene                   tr     1349
  35       Geranyl acetate              1.6    1363
  36       α-Copaene                    tr     1371
  37       β-Bourbonene                 0.2    1377
  38       β-Cubebene                   0.1    1385
  39       β-Elemene                    0.1    1389
  40       β-Caryophyllene              0.8    1420
  41       β-Copaene                    tr     1428
  42       trans-α-Bergamotene          tr     1433
  43       (E)-β-Farnesene              tr     1447
  44       α-Humulene                   0.1    1452
  45       Germacrene D                 0.5    1477
  46       β-Selinene                   tr     1483
  47       Myristicin                   1.6    1492
  48       δ-Cadinene                   0.1    1514
  49       Elemicin                     tr     1520
  50       Spathulenol                  tr     1565
  51       Caryophyllene oxide          0.1    1571
  52       β-Eudesmol                   tr     1625
  53       α-Eudesmol                   tr     1637
  54       Sclareoloxide                tr     1881
  55       Geranyllinalool              tr     1906
  56       Sclareol                     0.1    2206

tr \< 0.05%, % -- percentage of constituents, RI -- retention index.

The evaluation of *Staphylococcus* clinical strain resistance {#S20010}
-------------------------------------------------------------

Three of *Staphylococcus* genera were isolated from patients with wound infections, including *Staphylococcus* *aureus* (*n* = 28), and coagulase-negative species: *S. epidermidis* (*n* = 19) and *S. xylosus* (*n* = 14). The number of resistant *Staphylococcus* strains to recommended antibiotics is presented in [Figure 1](#F0001){ref-type="fig"}.

![*Staphylococcus* clinical strains isolated from wounds resistant to recommended antibiotics](PDIA-32-22363-g001){#F0001}

The results of susceptibility testing show that the *Staphylococcus* strains isolated from wound infections in the study were highly resistant to most of the β-lactam (penicillin), macrolide (erythromycin), lincosamides (clindamycin), tetracycline, fluoroquinolone (ciprofloxacin), aminoglycoside (gentamicin) antibiotics and sulfonamide (trimethoprim-sulfamethoxazole). *Staphylococcus aureus* clinical strains were much more resistant to recommended antibiotics than *S. epidermidis* and *S. xylosus* strains. There were 11 MRSA and 16 MSSA strains among the *S. aureus* isolates, but all of them were resistant to penicillin. The highest resistance of the coagulase-negative species was found for penicillin, erythromycin, tetracycline, ciprofloxacin, gentamicin and trimethoprim-sulfamethoxazole.

The susceptibility of *Staphylococcus* clinical strains to clary sage oil {#S20011}
-------------------------------------------------------------------------

The clary sage oil has the high antibacterial potential against all bacterial genera of *Staphylococcus* with MIC between 3.75--7.00 µl/ml. The approximate MIC values for *S. aureus* and *S. epidermidis* isolated from wounds were obtained. *Staphylococcus aureus* isolates including eleven MRSA and sixteen MSSA were inhibited by the clary sage oil at the concentrations of 3.75--5.25 µl/ml. The concentrations from 4.50 µl/ml to 6.25 µl/ml inhibited the growth of *S. epidermidis* clinical strains. Strains of *S. xylosus* were the least sensitive to *Salvia sclarea* oil, with the MIC values ranging from 6.25 µl/ml to 7.00 µl/ml. The activity of clary sage oil against *S. aureus*, *S. epidermidis* and *S. xylosus* is presented in [Figure 2](#F0002){ref-type="fig"}.

![The activity of clary sage oil against *Staphylococcus* clinical strains isolated from wounds](PDIA-32-22363-g002){#F0002}

Discussion {#S0012}
==========

The study results show that the *Salvia sclarea* essential oil has the strong antistaphylococcal activity against clinical strains isolated from wound infections. Interestingly, the strains of species *S. aureus* and *S. epidermidis* were more susceptible to the clary sage oil, followed by strains of *S. xylosus*. *Staphylococcus aureus* strains including MRSA were simultaneously the most resistant to recommended antibiotics. Linalyl acetate (57.9%) and linalool (12.4%) were found to be the main compounds out of 56 constituents of the clary sage oil. It should be emphasized that the oil tested in the present study was consistent with requirements of the European Pharmacopoeia 6 \[[@CIT0026]\] and the Polish Pharmacopoeia VIII \[[@CIT0027]\] which specify precise amounts of linalyl acetate (56--78%) and linalool (6.5--24%). The clary sage oil contains linalyl acetate (52.83%) and linalool (18.18%) which have been studied by Dźamić *et al*. \[[@CIT0020]\] and show the antifungal activity expressed as MIC in the range of 2.5 µl/ml to 25.0 µl/ml. Our previous studies demonstrated that the lavender oil at the concentration from 1.5 µl/ml to 3.0 µl/ml inhibited the growth of resistant *S. aureus* strains isolated from wounds \[[@CIT0028]\]. The composition of the analyzed lavender oil was similar to clary sage oil; linalyl acetate (33%) and linalool (34.1%) were the main constituents of oil from *Lavandula angustifolia Mill*. (*Lamiaceae*). The tested clary sage oil was active against all tested *S. aureus* clinical strains with MIC values ranging from 3.75 µl/ml to 5.25 µl/ml. The strains of *S. epidermidis* and *S. xylosus* were susceptible to the clary sage oil at the concentration from 4.50 µl/ml to 7.00 µl/ml. Peana *et al*. \[[@CIT0029]\] have proven that linalool and linalyl acetate play a major role in the anti-inflammatory activity of essential oils. They recommended all plant species producing these monoterpene compounds as potential anti-inflammatory agents. In recent years, anti-microbial, anti-inflammatory and immune stimulating properties of essential oils have become a subject of interest to clinicians. This is largely due to serious problems in the therapeutic treatment of recurrent infections caused by resistant pathogens. Research shows that many of the oils can be used in the treatment of wounds and skin infections. Riella *et al*. \[[@CIT0030]\] in their studies on animal models showed that essential oil from *Lippia gracilis* Schauer (*Verbenaceae*) with its major component -- thymol is a promising compound to be used in treatment of inflammatory processes as well as wound healing. According to Tavares *et al*. \[[@CIT0031]\], the essential oil from *Distichoselinum tenuifolium* (Lag.) Garcia Martin & Silvestre revealed significant antifungal activity against *Cryptococcus neoformans* and dermatophyte strains and significantly inhibited nitric oxide production stimulated by LPS in macrophages, without affecting cell viability at concentrations ranging from 0.64 µl/ml to 1.25 µl/ml. Yoon *et al*. \[[@CIT0032]\] proved that essential oil from *Abies koreana* can be used in the treatment of acne because of their antibacterial potential against *Propionibacterium acnes* and *S. epidermidis*. The tested oil reduced the LPS-induced secretion of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, nitric oxide and prostaglandin E(2) in RAW 264.7 macrophages, indicating that it has anti-inflammatory effects. Süntar *et al*. \[[@CIT0033]\] presented the interesting results connected with the use of a new ointment formulation to provide more efficient wound healing. This ointment containing essential oils from *Hypericum perforatum* L., *Origanum majorana* L., *Origanum minutiflorum* Schwrd. et Davis and *Salvia triloba* L. not only affected wound healing, but also exerted bactericidal and candicidal activities. Due to the enormous interest in staphylococci, including MRSA and coagulase-negative species that are increasingly being the cause of the difficult infections, the *Staphylococcus* genus was chosen for the investigations with clary sage oil. The studies of the clary sage oil activity against Gram-negative pathogens are also planned. The *Escherichia, Enterobacter, Acinetobacter, Citrobacter, Pseudomonas* and *Proteus* species which were isolated from recurrent, difficult-to-treat wound infections will be investigated. Our results may provide the basis for further research on the local use of the clary sage oil as a complement of existing anti-infective therapies in clinical conditions. Data on the antimicrobial activity of numerous plants have been scientifically confirmed inter alia against pathogenic microorganisms resistant to antimicrobials \[[@CIT0034], [@CIT0035]\].
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